VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Stock Comparison

CSL Limited vs Elixirr International plc

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

CSL Limited

CSL · ASX

Market cap (USD)$45B
Gross margin (TTM)48.9%
Operating margin (TTM)23.3%
Net margin (TTM)14.9%
SectorHealthcare
IndustryBiotechnology
CountryAU
Data as of2026-01-02
Moat score
77/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into CSL Limited's moat claims, evidence, and risks.

View CSL analysis

Elixirr International plc

ELIX · London Stock Exchange Main Market

Market cap (USD)$501M
Gross margin (TTM)31%
Operating margin (TTM)21.8%
Net margin (TTM)13.8%
SectorIndustrials
IndustryConsulting Services
CountryGB
Data as of2026-04-24
Moat score
52/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Elixirr International plc's moat claims, evidence, and risks.

View ELIX analysis

Comparison highlights

  • Moat score gap: CSL Limited leads (77 / 100 vs 52 / 100 for Elixirr International plc).
  • Segment focus: CSL Limited has 3 segments (71.7% in CSL Behring); Elixirr International plc has 1 segment (100% in Consulting services).
  • Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
  • Moat breadth: CSL Limited has 7 moat types across 3 domains; Elixirr International plc has 5 across 2.

Primary market context

CSL Limited

CSL Behring

Market

Plasma-derived therapies (immunoglobulins, albumin, coagulation factors) plus recombinant and gene therapies for rare and serious diseases

Geography

Global

Customer

Hospitals, specialty pharmacies, physicians; payers and national health systems

Role

Vertically integrated biopharma (plasma collection -> fractionation/manufacturing -> commercial distribution)

Revenue share

71.7%

Elixirr International plc

Consulting services

Market

Global strategy-led consulting, transformation, data, digital and AI advisory services

Geography

Global, with FY 25 revenue 63% USA, 22% UK and 15% Rest of World

Customer

Large enterprises, C-suite buyers, private-equity sponsors and portfolio companies

Role

Senior-led advisory, transformation and technology implementation partner

Revenue share

100%

Side-by-side metrics

CSL Limited
Elixirr International plc
Ticker / Exchange
CSL - ASX
ELIX - London Stock Exchange Main Market
Market cap (USD)
$45B
$501M
Gross margin (TTM)
48.9%
31%
Operating margin (TTM)
23.3%
21.8%
Net margin (TTM)
14.9%
13.8%
Sector
Healthcare
Industrials
Industry
Biotechnology
Consulting Services
HQ country
AU
GB
Primary segment
CSL Behring
Consulting services
Market structure
Oligopoly
Competitive
Market share
n/a
0%-0.1% (implied)
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
77 / 100
52 / 100
Moat domains
Supply, Legal, Demand
Demand, Supply
Last update
2026-01-02
2026-04-24

Moat coverage

Shared moat types

Operational ExcellenceProcurement Inertia

CSL Limited strengths

Supply Chain ControlPhysical Network DensityGovernment Contracting RelationshipsRegulated Standards PipeCapacity Moat

Elixirr International plc strengths

Brand TrustScope EconomiesEquity-aligned talent flywheel

Segment mix

CSL Limited segments

Full profile >

CSL Behring

Oligopoly

71.7%

CSL Seqirus

Oligopoly

13.9%

CSL Vifor

Oligopoly

14.4%

Elixirr International plc segments

Full profile >

Consulting services

Competitive

100%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.